Sarepta Therapeutics, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
13F-HR
144
3
3/A
4
4/A
424B3
424B4
424B5
424B7
425
5
8-A12B
8-A12G
8-K
8-K/A
8-K12B
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
FWP
POS AM
POSASR
PRE 14A
REGDEX
RW
S-1
S-3
S-3/A
S-3ASR
S-4
S-4/A
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-T
SC TO-T/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0000950170-25-108325 | Aug 13, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-103971 | Aug 6, 2025 | Jun 30, 2025 |
| S-8 | S-8 | 0001193125-25-174466 | Aug 6, 2025 | — |
| 4 | 4 | 0000950170-25-104397 | Aug 6, 2025 | Aug 5, 2025 |
| 4 | 4 | 0000950170-25-104398 | Aug 6, 2025 | Aug 5, 2025 |
| 4 | 4 | 0000950170-25-104399 | Aug 6, 2025 | Aug 5, 2025 |
| 4 | 4 | 0000950170-25-102279 | Aug 4, 2025 | Jul 31, 2025 |
| 3 | 3 | 0000950170-25-102276 | Aug 4, 2025 | Jul 16, 2025 |
| SCHEDULE 13G | — | 0001104659-25-070827 | Jul 25, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-070926 | Jul 25, 2025 | — |
| 8-K | 8-K | 0001193125-25-161516 | Jul 21, 2025 | — |
| 8-K | 8-K | 0000950170-25-096257 | Jul 16, 2025 | Jul 14, 2025 |
| 8-K | 8-K | 0000950170-25-083131 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-073954 | May 19, 2025 | May 16, 2025 |
| 4 | 4 | 0000950170-25-071961 | May 15, 2025 | May 13, 2025 |
| 10-Q | 10-Q | 0000950170-25-064412 | May 6, 2025 | Mar 31, 2025 |
| DEF 14A | DEF 14A | 0000950170-25-058003 | Apr 24, 2025 | Jun 5, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-058028 | Apr 24, 2025 | — |
| ARS | ARS | 0000950170-25-058059 | Apr 24, 2025 | Dec 31, 2024 |
| 4 | 4 | 0000950170-25-039037 | Mar 13, 2025 | Mar 12, 2025 |
| 144 | — | 0001972362-25-000284 | Mar 12, 2025 | — |
| 4 | 4 | 0000950170-25-037533 | Mar 11, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-037516 | Mar 11, 2025 | Mar 7, 2025 |
| 4 | 4 | 0000950170-25-037514 | Mar 11, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-037511 | Mar 11, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-037522 | Mar 11, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-037523 | Mar 11, 2025 | Mar 7, 2025 |
| 4 | 4 | 0000950170-25-037524 | Mar 11, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-037525 | Mar 11, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-037526 | Mar 11, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-037519 | Mar 11, 2025 | Mar 7, 2025 |
| 4 | 4 | 0000950170-25-037527 | Mar 11, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-037531 | Mar 11, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-037532 | Mar 11, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-036692 | Mar 10, 2025 | Mar 6, 2025 |
| 4 | 4 | 0000950170-25-036693 | Mar 10, 2025 | Mar 7, 2025 |
| 4 | 4 | 0000950170-25-036691 | Mar 10, 2025 | Mar 6, 2025 |
| 4 | 4 | 0000950170-25-036694 | Mar 10, 2025 | Mar 6, 2025 |
| 4 | 4 | 0000950170-25-036695 | Mar 10, 2025 | Mar 6, 2025 |
| 4 | 4 | 0000950170-25-035004 | Mar 6, 2025 | Mar 4, 2025 |
| 4 | 4 | 0000950170-25-035005 | Mar 6, 2025 | Mar 4, 2025 |
| 4 | 4 | 0000950170-25-035003 | Mar 6, 2025 | Mar 4, 2025 |
| 4 | 4 | 0000950170-25-035006 | Mar 6, 2025 | Mar 4, 2025 |
| 4 | 4 | 0000950170-25-035002 | Mar 6, 2025 | Mar 4, 2025 |
| 4 | 4 | 0000950170-25-032762 | Mar 4, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-032758 | Mar 4, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-032759 | Mar 4, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-032760 | Mar 4, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-032761 | Mar 4, 2025 | Mar 3, 2025 |
| S-3ASR | S-3ASR | 0001193125-25-044088 | Mar 3, 2025 | — |